The 20 Best Primary Localized Cutaneous Amyloidosis Doctors Near Me in Maryland, US

Joban Vaishnav is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. She has special interest in amyloidosis. Dr. Vaishnav earned her medical degree from St. Louis University School of Medicine. She completed a residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Vaishnav is rated as a Distinguished provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Cardiac Amyloidosis, Heart Failure, Primary Localized Cutaneous Amyloidosis, Heart Transplant, and Tissue Biopsy. Dr. Vaishnav is board certified in American Board Of Internal Medicine.

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as a Distinguished provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiac Amyloidosis, Heart Transplant, and Tissue Biopsy. Dr. Sharma is board certified in American Board Of Internal Medicine.

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

Dr. Rafael Llinas serves as the Director of Neurology at the Johns Hopkins Bayview Medical Center. His clinical interests include acute stroke treatments, neurovascular imaging and migraine as related to cerebrovascular disease. He also serves as the associate director of the neurology residency program. He was instrumental in establishing the Johns Hopkins Bayview Medical Center Stroke Center. In 2005, in recognition of the Stroke Centers organizational efforts in stroke care, the institution was granted certification as a Primary Stroke Center by the Joint Commission on Accreditation of Healthcare Organizations. Dr. Llinas primary areas of research interests include diffusion-perfusion imaging of stroke, intravenous and intra-arterial thrombolysis for stroke, education of physicians and nurses in stroke identification and stroke care, stroke units and stroke centers. Dr. Rafael Llinas received his medical degree from the New York University School of Medicine. He completed a medical internship at the Boston City Hospital and was a neurology resident in the Harvard-Longwood neurology training program. Following his residency, he was a stroke and cerebrovascular disease fellow for two years at Beth Israel Hospital, Harvard University. Dr. Llinas is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Stroke, Cerebral Amyloid Angiopathy, Siderosis, Thrombectomy, and Gastrostomy. Dr. Llinas is board certified in American Board Of Psychiatry And Neurology.

Stephen Gottlieb is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Gottlieb is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiomyopathy, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Barouch is Associate Professor of Medicine in the Division of Cardiology, Department of Medicine, and a member of the Advanced Heart Failure and Cardiac Transplantation group at Johns Hopkins Hospital. Dr. Barouch received her undergraduate degree from Harvard University in 1992 and her medical degree from Johns Hopkins in 1996. She continued at Johns Hopkins for residency training in Internal Medicine, completed in 1999, and fellowship in Cardiovascular Disease and Advanced Heart Failure/Transplant, completed in 2003. She has expertise in the outpatient management of advanced heart failure and many types of cardiomyopathies. Dr. Barouch also has a longstanding interest in women’s cardiovascular health – particularly in how some cardiac conditions affect women differently or present with distinctive symptoms. She is the Medical Director of the Columbia Heart Failure Clinic, in partnership with Johns Hopkins Howard County Medical Center, and the Howard County Director of the Women’s Cardiovascular Health Center. She is also the Director of the Sports Cardiology Program, which offers expert cardiac care specifically geared towards athletes of all abilities. Dr. Barouch believes that educating people about heart disease, medications and lifestyle changes, including healthy eating habits and regular exercise, is critically important in helping her patients understand how to achieve and maintain wellness and feel in control of their cardiovascular health. She is an avid runner and triathlete herself, competing in several triathlons and other races per year, as well as the occasional marathon. Dr. Barouch is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Cardiomyopathy, Cardiac Amyloidosis, Arrhythmogenic Right Ventricular Cardiomyopathy, and Primary Localized Cutaneous Amyloidosis. Dr. Barouch is board certified in American Board Of Internal Medicine.

Edward K. Kasper, M.D. is a graduate of the Johns Hopkins University with a B.A. in Natural Sciences. He earned his M.D. at the University of Connecticut School of Medicine in 1984. His internship and residency in Internal Medicine, as well as his fellowship in Cardiovascular Medicine, were completed at the Johns Hopkins Hospital, where he then joined the faculty in 1993. He is a fellow of the American Heart Association as well as a fellow of the American College of Cardiology, having served on its board of governors from 2002 to 2006. Dr. Kasper has authored more than 100 articles and three books including, Living Well with Heart Failure. He is currently the Director of Outpatient Cardiology. Dr. Kasper's current research interests focus on the biological origins of heart failure. Specifically, his research has focused on causes and prognosis of patients with cardiomyopathy, a serious condition in which the heart has difficulty pumping blood throughout the body. Dr. Kasper works closely with his team at the Johns Hopkins Heart and Vascular Institute to understand the best ways to predict and prevent catastrophic cardiac events. With your support, Dr. Kasper will be able to continue his significant work in cardiovascular medicine in hopes of impacting the future of patients with cardiomyopathy and heart failure. Dr. Kasper is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant. Dr. Kasper is board certified in American Board Of Internal Medicine.

Dr. Elisabeth Marsh's clinical interest is in cerebrovascular neurology, and her clinical research focuses on stroke outcomes and recovery. Her clinical responsibilities include attending on the inpatient Stroke Service at the Johns Hopkins Hospital and inpatient Neurology Service at the Johns Hopkins Bayview Medical Center. In 2014, Dr. Marsh was named the Medical Director of the Comprehensive Stroke Program at the Johns Hopkins Bayview Medical Center. She implemented the Bayview Stroke Intervention Clinic (BaSIC), a multi-disciplinary follow-up clinic designed to promote patient follow-up, reduce hospital readmission rates, and enhance post-stroke recovery. Her current focus is on the under-reported neurologic deficits (particularly with respect to depression, fatigue, and cognition) that significantly impair long-term functional outcome and patient satisfaction, despite scores on metrics such as the NIH stroke scale that indicate a “good recovery”. She leads a team of vascular neurologists, emergency medicine physicians, neurosurgeons, interventional neuroradiologists, neurointensivists, and rehabilitation specialists, who work together to provide the highest level of care to all stroke patients, resulting in better functional outcomes and improved quality of life. She is also interested in the treatment of acute stroke and intracranial hemorrhage. Her past work has included evaluation of the predictors of hemorrhagic transformation following ischemic stroke. Using multivariable regression, she created a model that predicts rate of hemorrhagic transformation in patients with acute stroke on anticoagulation, the Hemorrhage Risk Stratification (HeRS) score. The tool is available for free through Apple by searching 'Johns Hopkins HeRS score' in the App Store. Dr. Marsh is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Stroke, Apoplexy, Transient Ischemic Attack (TIA), Thrombectomy, and Gastrostomy. Dr. Marsh is board certified in American Board Of Psychiatry And Neurology.

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease. Dr. Mixter is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

Steven Hsu, M.D., is a member of the Johns Hopkins Medicine Division of Cardiology, specializing in heart failure, mechanical circulatory support, and cardiac transplantation. Dr. Hsu received his undergraduate degree from Yale College followed by his medical degree from the Johns Hopkins University School of Medicine. He completed intern and residency training in internal medicine at the Johns Hopkins Hospital, where he also served as an Assistant Chief of Service for the Osler Medical Service. He then completed a clinical fellowship in cardiology and a post-doctoral fellowship in advanced heart failure/transplant at Hopkins. He is a faculty member of the American College of Cardiology. He sees patients with heart failure, mechanical circulatory support devices such as left ventricular assist devices, and cardiac transplants. In addition to caring for patients, Dr. Hsu runs an NIH R01-funded research lab studying the hemodynamic and cellular changes related to right ventricular failure in the setting of pulmonary hypertension and heart failure. Dr. Hsu is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, and Pulmonary Hypertension. Dr. Hsu is board certified in American Board Of Internal Medicine.

Dr. Richard Leigh is an Assistant Professor of Neurology who is devoted to the diagnosis, treatment and prevention of cerebrovascular disease. He is an attending on the inpatient stroke service and an integral part of the Brain Attack Team. He also provides consultations and follow-up care for cerebrovascular disease in the outpatient setting. Dr. Richard Leigh was originally trained as a biomedical engineer at the Johns Hopkins University and subsequently went on to work at the National Institutes of Health where he developed brain imaging software. He then embarked on obtaining his medical degree from Case Western Reserve School of Medicine in his home town of Cleveland, Ohio. He completed his medical internship and neurology residency at New York Presbyterian Hospital Weill Cornell Medical Center where he received the Distinguished House Staff Award and was selected to be Chief Resident of Neurology. Returning to Johns Hopkins, he then completed a stroke fellowship and subsequently joined the faculty of the cerebrovascular division. Dr. Leigh currently sees patients at the Stroke Prevention Clinic, located in the Johns Hopkins Outpatient Center in Baltimore on Wednesday afternoons, and cares for patients in The Johns Hopkins Hospitals Brain Rescue Unit. Dr. Leigh is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His clinical expertise encompasses Stroke, Primary Localized Cutaneous Amyloidosis, Cardiac Amyloidosis, and Cerebral Amyloid Angiopathy. Dr. Leigh is board certified in American Board Of Psychiatry And Neurology.

Dr. Michael Kelemen is a general cardiologist for the Johns Hopkins Heart and Vascular Institute in the Department of Medicine. His research in cardiac rehabilitation demonstrated the power of exercise as a treatment for hypertension, high cholesterol, and recovery from cardiac events. Dr. Kelemen is an associate professor of medicine in the Johns Hopkins School of Medicine. Dr. Kelemen received his medical degree from the University of Pennsylvania Health System School of Medicine. He completed his residency in medicine at University Hospitals of Cleveland, and pursued cardiology fellowships at the University of California, San Francisco School of Medicine and at the Wyman Park Health System in Baltimore. Dr. Kelemen is active in community health issues, having served on the boards of the Health Alliance and The Horizon Foundation, which provide medical and mental health services to underserved populations. As the founding medical director of the Prescribed Active Cardiac Exercises (PACE) program at Catonsville Community College in 1976, he performed the research that demonstrated the benefits of exercise for cardiac patients. Dr. Kelemen is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Heart Attack, Apoplexy, Postural Orthostatic Tachycardia Syndrome (POTS), and Short QT Syndrome. Dr. Kelemen is board certified in American Board Of Internal Medicine.

Neurologist Michelle C. Johansen specializes in prevention and treatment of stroke. She is the inaugural Guy McKhann Associate Professor of Neurology — the title was established in honor of the founder of the Johns Hopkins Department of Neurology. Dr. Johansen’s research and clinical interests focus on stroke etiology and vascular contributions to cognitive decline. She studies the intersection between the brain and the heart, specifically how changes in the heart’s structure and function point toward the cause of stroke and impact brain health, including cognition. She received the American Stroke Association’s Vascular Cognitive Impairment Award for her work showing that myocardial infarction is associated with acute and progressive decline in cognition, the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Johns Hopkins Department of Neurology’s Clinical Faculty Brain Award for excellence in teaching. She has received multiple grants to fund her research from the National Institute of Neurological Disorders and Stroke, the National Institute on Aging and the American Heart Association. Dr. Johansen’s work has been published in many high-ranking medical journals such as The Journal of the American Medical Association, and she has been interviewed as an expert for news outlets such as CNN and Medical News Today, as well as for webinars and podcasts. She is a member of the American Neurological Association and chair of its Education Innovation Committee, and she is a fellow of the American Heart Association. She received her medical degree from the Medical College of Virginia, where she was inducted into the Alpha Omega Alpha Honor Society, and she earned a postdoctoral degree in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Johansen completed a medicine internship and neurology residency at the University of Virginia, followed by a clinical fellowship in cerebrovascular neurology at Johns Hopkins. She joined the Johns Hopkins Department of Neurology faculty in 2017. The Johansen Lab: johansenlab.org Videos Johns Hopkins Medicine A Woman's Journey Executive Women's Briefing 2021 Neurology: Junior Faculty Spotlight. Dr. Johansen is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Stroke, Dementia, Cerebral Amyloid Angiopathy, Apoplexy, and Thrombectomy. Dr. Johansen is board certified in American Board Of Psychiatry And Neurology.

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Lupus Nephritis, Glomerulonephritis, Chronic Kidney Disease, and Kidney Transplant.

Merrill Ansher is a Neurologist practicing medicine in Columbia, Maryland. Dr. Ansher is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Seizures, Familial Neurocardiogenic Syncope, Delirium, and Generalized Tonic-Clonic Seizure. Dr. Ansher is board certified in American Board Of Psychiatry And Neurology and American Board Of Internal Medicine.

1988-1992, Assistant Professor, Department of Pharmacology, Semmelweis Medical University, Budapest, Hungary. 1992-1996, Instructor, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 2001-2014, Assistant Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2012-2014, Assistant Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Associate Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. Dr. Yasar is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Normal Pressure Hydrocephalus, Congenital Cardiovascular Shunt, Dementia, and Alzheimer's Disease. Dr. Yasar is board certified in American Board Of Internal Medicine.

Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy. Dr. Hillis is board certified in American Board Of Psychiatry And Neurology.

Sabra Lewsey is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. Dr. Lewsey earned her medical degree from Columbia University College of Physicians & Surgeons and a master of public health degree from Harvard School of Public Health. She completed her residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Lewsey is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, and Heart Transplant. Dr. Lewsey is board certified in American Board Of Internal Medicine.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy. Dr. Naik is board certified in American Board Of Internal Medicine.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Supraventricular Tachycardia (PSVT), Multifocal Atrial Tachycardia, His Bundle Tachycardia, Cardiac Ablation, and Tissue Biopsy. Dr. Cingolani is board certified in American Board Of Internal Medicine.